June 8, 2022 – A Highly Contiguous Draft Reference Genome for the Psilocybe Cubensis Mushroom Is Now Available – A brief summary of a new peer-reviewed paper detailing the assembly of a highly contiguous draft reference genome for the Psilocybe cubensis mushroom by Kevin McKernan, Medicinal Genomics Chief Science Officer, and colleagues.
June 2, 2022 – How Do You Know You’re Right? qPCR vs. Plating – Cannabis testing to detect microbial contamination is complicated. It may not be rocket science, but it is life science, which means it’s a moving target, or at least, it should be, as we acquire more and more information about how the world we live in works.
May 3, 2022 – Dr. Raphael Mechoulam And Other Cannabis Scientists Attend CannMed 2022 Conference In Pasadena – CannMed, a yearly event to prioritize cannabis science, innovation and collaboration is getting underway in Pasadena, California May 3-5.
March 1st, 2022 – Medicinal Genomics Salmonella and STEC E. coli Multiplex Assay Certified by AOAC – AOAC certified the Medicinal Genomics PathoSEEK® Salmonella and STEC E. coli multiplex assay. The platform now has more cannabis matrices accredited for Aspergillus, Salmonella, and STEC E. coli than any other product, according to a press release.
August 10, 2022 – 5 Viruses to Watch Out for in Your Cannabis Grow – we interviewed Liam Kane, R&D Scientist at Medicinal Genomics, about each virus and its role in cannabis. Liam has designed and internally validated all of Medicinal Genomics’ cannabis virus assays, including but not limited to: the primer design, testing with various Master Mixes, and an assay optimization process.
May 26, 2022 – Mold in medical marijuana? Yes, and here’s what Connecticut is doing about it. – The Department of Consumer Protection brought in Sherman Hom, director of regulatory affairs for Medicinal Genomics, on May 10 to speak with committee members and answer their questions. DCP Commissioner Michelle Seagull was also present, said department spokeswoman Kaitlyn Krasselt.
May 13, 2022 – Cannabis Healthcare for the Nation: CannMed Returns – CannMed, the premium industry meeting for cannabis science run by Medicinal Genomics (the world leader in cannabis genetics and microbial detection), returned for its first in-person event in more than two years May 3-5, bringing scientists and thought leaders from around the planet to Pasadena, California, for three days of education, exhibiting and patient-focused networking.
Apr 28, 2022 – CannMed highlights advances in ‘Mother Nature’s pharmacy’ – CannMed 2022 will bring together industry leaders, the latest innovations and research as well as the “father of cannabis research” to the Pasadena Convention Center Tuesday, May 3, to Thursday, May 5.
Media Contact: info@medicinalgenomics.com
©2023 MEDICINAL GENOMICS CORPS
Copyright all right reserved.
Signup to receive email updates on blog posts, podcasts, webinars, new products, and more!
Join us at the CannMed 23 Innovation and Investment Summit, an exclusive experience of discovery, development, and networking with innovators from around the world.
